Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
about
Eat dirt: CpG DNA and immunomodulation of asthmaLocal therapy with CpG motifs in a murine model of allergic airway inflammation in IFN-beta knock-out miceCpG ODNs treatments of HIV-1 infected patients may cause the decline of transmission in high risk populations - a review, hypothesis and implications.Prophylactic administration of bacterially derived immunomodulators improves the outcome of influenza virus infection in a murine model.Nasolacrimal duct closure modulates ocular mucosal and systemic CD4(+) T-cell responses induced following topical ocular or intranasal immunization.The genetic and environmental basis of atopic diseases.House dust mite allergy: environment evaluation and disease prevention.Allergen-responsive CD4+CD25+ regulatory T cells in children who have outgrown cow's milk allergy.Regulatory T cells contribute to allergen tolerance induced by daily airway immunostimulant exposures.Molecular adjuvants for mucosal immunity.Antigen-immunostimulatory oligonucleotide conjugates: mechanisms and applications.A limited CpG-containing oligodeoxynucleotide therapy regimen induces sustained suppression of allergic airway inflammation in mice.Nanoparticle conjugation enhances the immunomodulatory effects of intranasally delivered CpG in house dust mite-allergic mice.Immunostimulatory oligonucleotides in therapy of allergic diseases.Update on toll-like receptor-directed therapies for human diseaseAnimal models of allergen-induced tolerance in asthma: are T-regulatory-1 cells (Tr-1) the solution for T-helper-2 cells (Th-2) in asthma?The 'microflora hypothesis' of allergic diseases.Update on toll-like receptor ligands and allergy: implications for immunotherapy.Subcutaneous late phase responses are augmented during local inhalational tolerance in a murine asthma modelAirway house dust extract exposures modify allergen-induced airway hypersensitivity responses by TLR4-dependent and independent pathways.Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma.Role of antibiotics and fungal microbiota in driving pulmonary allergic responses.Immune modulatory oligonucleotides in the prevention and treatment of OVA-induced eustachian tube dysfunction in rats.Prolonged antigen ingestion by sensitized mice ameliorates airway inflammation.Allergen-independent immunostimulatory sequence oligodeoxynucleotide therapy attenuates experimental allergic rhinitis.Immunomodulatory effects of CpG oligodeoxynucleotides on house dust mite-induced airway inflammation in mice.Immunostimulatory oligodeoxynucleotide containing TTTCGTTT motif from Lactobacillus rhamnosus GG DNA potentially suppresses OVA-specific IgE production in mice.Proteolytically inactive per a 10 allergen of Periplaneta americana modulates Th2 response and enhances IL-10 in mouse model.Immunostimulatory sequence CpG elicits Th1-type immune responses in inflammatory skin lesions in an atopic dermatitis murine model.
P2860
Q24648479-43544727-7B29-4E1B-8FCB-6017618C4A38Q24804175-56D3878D-1018-49BA-AD27-51EDC8BE980EQ30350301-117F7E27-0174-45B4-95A8-995B4B58287BQ33676552-D1D557D5-7A54-4F8C-B822-C6706EDE9E6DQ33725145-249F3088-3043-46E6-82BC-210AA55E66A8Q34012654-E822CDDC-8CC4-4E72-8484-3692E63672DBQ34432074-80DF2699-9C2F-4121-A639-50F8F5C9A25FQ34548646-C0B69310-0A22-4A56-B0F4-DD5C23993AB3Q34985458-30FD7934-EB58-4F94-A286-B7CACCB0DA04Q35826381-249283B2-D79F-465D-BF73-FB8E7D5B7F4DQ35826408-3E389907-CC41-43B0-AD58-5E8BA9B36712Q36023560-42E7DAB3-352B-4FAC-9154-D9E1434D3A3FQ36099185-CA96F0AA-E357-44EA-959E-5914C42C5CA3Q36150438-C73B2E39-BAAE-4CA0-9E6C-484FD76C516AQ36171745-ADD4A625-59D3-4764-82E1-ACE51DAC16C7Q36360525-DD866DBC-49F5-4714-98F9-77DA8C4EB4F7Q36360555-4E3675C2-B37F-466D-99C3-48FBC65988B8Q36561236-6D6E5EC0-656F-4E44-B2E1-BC89E9730EBFQ36957741-530B720B-70B8-4755-8192-670A21B12E7BQ36983216-E59C20CA-D786-42BF-8FF4-778F2300DAAFQ37196833-23EFD8ED-9EBF-4B80-AC0C-887B78E4DD5FQ37521749-E53C705D-EBF7-4224-A8E5-86DAC2343B36Q40188066-BAE9CF4F-4BFC-46A3-84EC-4407F4DA2FE5Q40846423-F80A34F6-88DC-4FEA-9A38-BEF1EB87CD93Q45018823-E3B7B143-0EEB-4989-A4C9-89932AC75F18Q46619562-3544BE27-296F-4DB8-8883-CF9FB3CCCAA5Q51791575-2E8743E8-FFE5-42AE-B922-3B0DD82CEF4AQ52700761-12D4A9F9-1050-4026-9BBF-1AFB21FB3F9BQ54534853-D215BEF8-1086-4C41-B5C8-3AEF3A712B8D
P2860
Intranasal immunotherapy is more effective than intradermal immunotherapy for the induction of airway allergen tolerance in Th2-sensitized mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@en
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@nl
type
label
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@en
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@nl
prefLabel
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@en
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@nl
P2093
P1476
Intranasal immunotherapy is mo ...... erance in Th2-sensitized mice.
@en
P2093
Anthony A Horner
Dugald Chisholm
Jose Zubeldia
Kenji Takabayashi
P304
P356
10.4049/JIMMUNOL.170.7.3898
P407
P577
2003-04-01T00:00:00Z